Skip to main content
GENESIS IBRC INDIA LIMITED logo

GENESIS IBRC INDIA LIMITED — Investor Relations & Filings

Ticker · 514336 ISIN · INE194N01016 BSE.NS Manufacturing
Open in API
Filings indexed 311 across all filing types
Latest filing 2025-05-21 Regulatory Filings
Country IN India
Listing BSE.NS 514336

About GENESIS IBRC INDIA LIMITED

https://genesisiil.com/

Genesis IBRC India Limited is a biotechnology-driven enterprise focused on the research, development, and commercialization of advanced biological solutions. The company specializes in the production of high-quality probiotics and industrial enzymes tailored for diverse applications. Its product portfolio serves critical sectors including aquaculture, poultry, animal husbandry, and human nutrition, providing microbial formulations designed to enhance growth, immunity, and overall health. In the industrial segment, the company develops enzymatic solutions for the textile, leather, and paper processing sectors to improve efficiency and environmental sustainability. Genesis IBRC emphasizes innovation through its dedicated research facilities, focusing on strain selection and fermentation technology to deliver standardized and effective biochemical products. The company aims to provide science-based alternatives to traditional chemical processes across global markets.

Recent filings

Filing Released Lang Actions
Genesis Ibrc India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve With reference to the subject ....
Regulatory Filings Classification · 95% confidence The document is a notice from Genesis IBRC India Limited to the Bombay Stock Exchange about an upcoming Board Meeting scheduled for May 29, 2025. The purpose of the meeting is to consider and approve the Audited Financial Results for the quarter and financial year ended March 31, 2025. The document is short (1314 characters) and serves as an announcement of a meeting rather than containing any financial data or results itself. It references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, which pertains to disclosures about board meetings. Since this is a notice of a board meeting and not the actual financial report or results, it does not qualify as an Annual Report, Interim Report, or Earnings Release. It is also not a Board/Management Information announcement about changes in directors or management. The best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories. Confidence is high due to clear identification of the document as a meeting notice without substantive financial data.
2025-05-21 English
Certificate under Regulation74(5) of SEBI (DP) Regulations
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 31st March 2025. It is a compliance certificate from the Registrar and Transfer Agent confirming dematerialisation and updating of securities records. The document is addressed to the stock exchange and is a regulatory compliance filing rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data, nor is it an announcement of a report publication. It is primarily a regulatory compliance certificate. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length is short (2656 characters), consistent with a certificate or regulatory filing rather than a full report.
2025-04-19 English
Closure of Trading window from 1st April 2025 till the 48 hours of financial result for the year ended 31.03.2025.
Regulatory Filings Classification · 95% confidence The document is a formal letter from Genesis IBRC India Limited addressed to the Corporate Relations Department of BSE Limited. It informs about the closure of the trading window for insiders in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The closure period is specified around the declaration of audited financial results for the fiscal year ending 31st March 2025. The document does not contain any financial data, results, or detailed report but is an announcement related to trading restrictions ahead of financial results disclosure. It is short (1486 characters) and serves as a regulatory notification rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and regulatory announcements that do not fit other specific categories.
2025-03-25 English
Swaraj Shares and Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Draft Letter of Offer to the Public Shareholders of Genesis Ibrc India Ltd ("Target Company").
Regulatory Filings
2025-03-20 English
Swaraj Shares and Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Detailed Public Statement in accordance with the Provisions of Regulations 13(4), 14(3), and ....
Regulatory Filings
2025-03-12 English
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for V Varalakshmi & PACs
Regulatory Filings
2025-03-10 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.